Vanderbilt University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Vanderbilt University sits in the top decile of US sponsors by registered trial count (#83 of 15,742 sponsors by registered trial count).
Vanderbilt University: 430 sponsored US clinical trials, 15 recruiting.
Vanderbilt University sponsors 430 registered US clinical trials on ClinicalTrials.gov, 15 of them currently recruiting, and 343 completed. 42 of these trials are in Phase 3-4 (later-stage) and 92 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 8 trials.
Top-decile sponsor footprint
Vanderbilt University ranks in the top decile of sponsors by registered trial count (#83 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
343 of 401 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
430 total, page 9 of 9
Genetic and Environmental Characteristics of Primary Pulmonary Hypertension
NCT00091546
The Effects of Pentoxifylline on PAI-1 in an Obese Population
NCT00770328
Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant
NCT00179049
Repository: Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant
NCT00179075
The Autonomic Nervous System and Obesity
NCT00179023
Prevention of Depression in At-Risk Adolescents
NCT00073671
Biological, Genetic, and Lifestyle Risk Factors for Developing Colorectal Adenomas or Polyps in Participants Undergoing Colonoscopy
NCT00625066
The Effects of Protein Supplementation and Resistance Exercise in Hemodialysis Patients
NCT00179140
Prevention of Recurrence in Depression With Drugs and CT
NCT00057577
Center for Reducing Asthma Disparities - Meharry/Vanderbilt Centers
NCT00281151
Effects of Treating Obstructive Sleep Apnea in Epilepsy
NCT00047463
Nitric Oxide and the Autonomic Nervous System
NCT00178919
Vanderbilt University Spasticity Management Program Evaluation Plan
NCT00179114
Sertraline vs. Venlafaxine XR
NCT00179283
Sympathetic Nerve Activity During Hypoglycemia and Exercise
NCT00608348
Treatment of Orthostatic Hypotension in Autonomic Failure
NCT00223691
A National Registry of Patients With Hepatocellular Carcinoma
NCT00178867
Chemotherapy Toxicity Reduction Via Urea Cycle Support
NCT00223730
Real-World Benefit From Directional Hearing Aids
NCT00438334
Cetuximab in Treating Patients With Ménétrier Disease at High Risk of Developing Stomach Cancer
NCT00477880
Mechanisms of Hypoglycemia Associated Autonomic Dysfunction, Q.3
NCT00742521
Patient Sleep Position Questionnaire
NCT00338013
Treatment of Supine Hypertension in Autonomic Failure
NCT00223717
Optic Nerve Sheath Fenestration
NCT00337961
Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder
NCT00179062
Acoustical Properties of Speech as Indicators of Suicidal Risk
NCT00178906
Effect of Gastric Bypass on Patients With Type 2 Diabetes and/or Dyslipidemia
NCT00879125
Selenium Supplementation of Patients With Cirrhosis
NCT00212186
Effects of Nutritional Supplementation on Protein and Energy Homeostasis in Malnourished Chronic Hemodialysis Patients
NCT00244075
Endoscopic Goniotomy for Infantile Glaucoma
NCT00338533
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 50 |
| Phase 2 | 42 |
| Phase 3 | 10 |
| Phase 4 | 32 |
Therapeutic Areas
What is open in the Vanderbilt University pipeline
15 recruiting of 430 indexed (3% open); 343 completed (80%).
Phase mix: 42 late (III/IV) vs 92 early (I/II) (early-phase heavy).
Top condition: Obesity (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Vanderbilt University: open-pipeline peers nationwide
Peers matched on 430 registered trials and 3% open enrollment, not the therapeutic-area sidebar.
Vanderbilt University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 430 trials (± recruiting share)
- University of Illinois at Chicago · 430 trials · 27% recruiting
- Children's Hospital of Philadelphia · 431 trials · 18% recruiting
- Novo Nordisk A/S · 431 trials · 8% recruiting
- Dartmouth-Hitchcock Medical Center · 427 trials · 12% recruiting
Sponsors near 3% open enrollment (± trial volume)
- USDA Grand Forks Human Nutrition Research Center · 4% recruiting · 57 trials
- Medtronic MiniMed · 3% recruiting · 29 trials
- Sandoz · 3% recruiting · 29 trials
- Sonova · 3% recruiting · 29 trials
Related
What to do with this Vanderbilt University page
430 registered trials is a research-attention snapshot, not an endorsement of Vanderbilt University or any single study.
- 15 of Vanderbilt University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Vanderbilt University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Vanderbilt University pipeline card: 430 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.